TIL (Instil Bio, Inc. Common Stock) Stock Analysis - SEC Filings
Instil Bio, Inc. Common Stock (TIL) is a publicly traded Healthcare sector company. As of May 21, 2026, TIL trades at $8.02 with a market cap of $55.14M and a P/E ratio of -0.76. TIL moved +1.25% today. Year to date, TIL is -34.74%; over the trailing twelve months it is -51.22%. Its 52-week range spans $5.67 to $70.16. Rallies surfaces TIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Where can I find TIL SEC filings?
Rallies organizes TIL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Laumas Sandeep sold 17.54K (~$404.10K) on Sep 10, 2025.
Laumas Sandeep sold 12.46K (~$297.57K) on Sep 10, 2025.
Vivo Capital IX, LLC bought 300.00K (~$6.00M) on Mar 23, 2021.
TIL Analyst Consensus
TIL analyst coverage data. Average price target: $0.00.
Common questions about TIL
Where can I find TIL SEC filings?
Rallies organizes TIL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TIL 10-K and 10-Q filings?
Rallies organizes TIL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TIL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TIL. It does not provide personalized investment advice.